China-based Joincare Pharmaceutical Group Industry Co., Ltd (SHA: 600380) announced plans to issue Global Depository Receipts (GDRs) on the SIX Swiss Exchange. The proceeds will be used to support international business development and accelerate global expansion. The fundraising size is expected to be in the region of USD 300-400 million, though the final amount remains to be determined. The offering, led by CITIC Securities, is subject to approval from shareholders and regulators in both China and Switzerland.
Strategic Goals
Joincare Pharmaceutical’s strategic goal is to establish a high-barrier complex preparation technology platform. This initiative aims to enhance the company’s research and development capabilities and strengthen its position in the global pharmaceutical market.
Market Expansion
The company has been actively expanding its product portfolio and market presence in Southeast Asia and South Asia. Joincare has intensified efforts to promote its respiratory, assisted reproduction, antifungal, antiviral, digestive tract, and other product lines in these regions, aligning with its broader international growth strategy.-Fineline Info & Tech
